BACKGROUND: Disparity in access to liver transplantation (LT) in the United States persists despite directives from the federal government to reduce geographic variation. We assessed the impact of socioeconomic status (SES) and traveling to alternative donation service areas (DSAs) on patient survival. METHODS: A prospective cohort study integrating transplant registry and U.S. Census data was analyzed using multivariate linear Cox proportional hazards models. A separate matched-pairs analysis was used to assess the benefit of traveling on patient survival and transplantation rate. RESULTS: High SES is associated with increased access to LT (adjusted hazard ratio [aHR], 1.05; 95% confidence interval [95% CI], 1.01-1.08) and reduced mortality after waitlisting (aHR [95% CI], 0.88 [0.85-0.93]). Increased access is mediated, in part, through inter-DSA travel. Travel was associated with high SES, white race, blood group O, private insurance, and residence in regions 1, 5, and 11. Transplant candidates in the highest SES quartile were approximately 70% more likely to travel (aHR [95% CI], 1.67 [1.43-1.97]) than those in the lowest SES quartile. Compared with matched control patients, travelers were 74% more likely to be transplanted (aHR [95% CI], 1.74 [1.56-1.94]) and 20% less likely to die after listing (aHR [95% CI], 0.79 [0.69-0.92]). CONCLUSION: High SES and inter-DSA travel are strongly associated with increased LT access and reduced mortality. Travelers are more likely to be sociodemographically advantaged and privately insured and to live in regions with reduced access to deceased-donor organs.
BACKGROUND: Disparity in access to liver transplantation (LT) in the United States persists despite directives from the federal government to reduce geographic variation. We assessed the impact of socioeconomic status (SES) and traveling to alternative donation service areas (DSAs) on patient survival. METHODS: A prospective cohort study integrating transplant registry and U.S. Census data was analyzed using multivariate linear Cox proportional hazards models. A separate matched-pairs analysis was used to assess the benefit of traveling on patient survival and transplantation rate. RESULTS: High SES is associated with increased access to LT (adjusted hazard ratio [aHR], 1.05; 95% confidence interval [95% CI], 1.01-1.08) and reduced mortality after waitlisting (aHR [95% CI], 0.88 [0.85-0.93]). Increased access is mediated, in part, through inter-DSA travel. Travel was associated with high SES, white race, blood group O, private insurance, and residence in regions 1, 5, and 11. Transplant candidates in the highest SES quartile were approximately 70% more likely to travel (aHR [95% CI], 1.67 [1.43-1.97]) than those in the lowest SES quartile. Compared with matched control patients, travelers were 74% more likely to be transplanted (aHR [95% CI], 1.74 [1.56-1.94]) and 20% less likely to die after listing (aHR [95% CI], 0.79 [0.69-0.92]). CONCLUSION: High SES and inter-DSA travel are strongly associated with increased LT access and reduced mortality. Travelers are more likely to be sociodemographically advantaged and privately insured and to live in regions with reduced access to deceased-donor organs.
Authors: Christine E Haugen; Tanveen Ishaque; Abel Sapirstein; Alexander Cauneac; Dorry L Segev; Sommer Gentry Journal: Am J Transplant Date: 2019-03-18 Impact factor: 8.086
Authors: Sommer E Gentry; Eric K H Chow; Allan Massie; Xun Luo; Eugene Shteyn; Joshua Pyke; David Zaun; Jon J Snyder; Ajay K Israni; Bert Kasiske; Dorry L Segev Journal: Liver Transpl Date: 2015-08 Impact factor: 5.799
Authors: Allyson Hart; David P Schladt; Jessica Zeglin; Joshua Pyke; W Ray Kim; John R Lake; John P Roberts; Ryutaro Hirose; David C Mulligan; Bertram L Kasiske; Jon J Snyder; Ajay K Israni Journal: Transplantation Date: 2016-10 Impact factor: 4.939
Authors: Fawaz Al Ammary; Alvin G Thomas; Allan B Massie; Abimereki D Muzaale; Ashton A Shaffer; Brittany Koons; Mohamud A Qadi; Deidra C Crews; Jacqueline Garonzik-Wang; Hai Fang; Daniel C Brennan; Krista L Lentine; Dorry L Segev; Macey L Henderson Journal: Am J Transplant Date: 2019-02-08 Impact factor: 8.086
Authors: Jayme E Locke; Brittany A Shelton; Kim M Olthoff; Elizabeth A Pomfret; Kimberly A Forde; Deirdre Sawinski; Meagan Gray; Nancy L Ascher Journal: JAMA Surg Date: 2020-07-15 Impact factor: 14.766
Authors: Chiranjeevi Gadiparthi; George Cholankeril; Eric R Yoo; Menghan Hu; Robert J Wong; Aijaz Ahmed Journal: Dig Dis Sci Date: 2018-04-02 Impact factor: 3.199
Authors: Kristopher P Croome; David D Lee; Justin M Burns; Dana K Perry; Andrew P Keaveny; C Burcin Taner Journal: PLoS One Date: 2015-10-15 Impact factor: 3.240